It is a pharma public limited company based in Panchkula, Haryana, India, established in 2019.
2019 | Panchkula, Haryana, India | ActiveMoselle Drugs And Cosmetics Limited, a active public limited company, was established on 10 January 2019 in Panchkula, Haryana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24290HR2019PLC077772. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.10 Cr and a paid-up capital of ₹1.87 Cr.
It upholds a compliant status. Its leadership includes Ganapathy Venkatachalam Iyer (Director), Gurmeet Singh Narula (Director), Reji Joy (Director). Past directors included Parvinder Singh Gulati, Suman Kumar Sinha. It holds ₹2.50 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at House No. 1030, Sector 2,, Panchkula, Haryana, 134112.
U24290HR2019PLC077772
077772
10 January 2019
₹2.10 Cr
₹1.87 Cr
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Moselle Drugs And Cosmetics Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ganapathy Venkatachalam Iyer | Director | 10 Jan 2019 | Current |
| Gurmeet Singh Narula | Director | 10 Jan 2019 | Current |
| Reji Joy | Director | 10 Jan 2019 | Current |
| Peter Jose Ansal Parriathcherry | Director | 10 Jan 2019 | Current |
| Sham Lal Singla | Director | 10 Jan 2019 | Current |
| Pudugrammam Krishna Iyer Vaidyanathan | Director | 10 Jan 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 03 Jan 2024 | Past |
| Pramod Abcsdd | Director | 26 Aug 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Moselle Drugs And Cosmetics Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 34.56% decrease in profit. The company's net worth observed a substantial decline by a decrease of 19.3%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Moselle Drugs And Cosmetics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹25,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Oct 2022 | Axis Bank Limited | ₹2.50 Cr | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Moselle Drugs And Cosmetics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Moselle Drugs And Cosmetics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Moselle Drugs And Cosmetics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Moselle Drugs And Cosmetics Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Moselle Drugs And Cosmetics Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
The activity A charge with Axis Bank Limited amounted to Rs. 2.50 Cr with Charge ID 100627733 was registered on 19 Oct 2022. was completed.
Ganapathy Venkatachalam Iyer was appointed as a Director was appointed as a Director on 10 Jan 2019 & has been associated with this company since 7 years 9 days . was recorded as a recent event.
The activity Gurmeet Singh Narula was appointed as a Director was appointed as a Director on 10 Jan 2019 & has been associated with this company since 7 years 9 days . was completed.
The activity Reji Joy was appointed as a Director was appointed as a Director on 10 Jan 2019 & has been associated with this company since 7 years 9 days . was completed.
The CIN of Moselle Drugs And Cosmetics Limited is U24290HR2019PLC077772.
Moselle Drugs And Cosmetics Limited is headquartered at House No. 1030, Sector 2,, Panchkula, Haryana, 134112.
Moselle Drugs And Cosmetics Limited was incorporated on 10 January 2019.
The current directors of Moselle Drugs And Cosmetics Limited are
The primary industry of Moselle Drugs And Cosmetics Limited is Manufacturing.
Moselle Drugs And Cosmetics Limited is unlisted.
The authorized capital of Moselle Drugs And Cosmetics Limited is ₹2.10 Cr, and the paid-up capital is ₹1.87 Cr.
The compliance status of Moselle Drugs And Cosmetics Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX